THRX — Theseus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $181.72m
- -$23.40m
Brief: Theseus Pharmaceuticals Gets U.S. FDA Orphan Drug Designation For THE-630
Brief: Theseus Pharmaceuticals Announces First Patient Treated With The-630 In Phase 1/2 Study In Patients With Advanced Gastrointestinal Stromal Tumors
U.S. STOCKS ON THE MOVE-Adobe, Under Armour, Lennar, gold stocks
Brief: Theseus Pharmaceuticals Announces Business And Program Highlights And Reports Third Quarter 2021 Financial Results
Brief: Theseus Pharmaceuticals Announces FDA Clearance Of Investigational New Drug Application For THE-630
Brief: Theseus Pharmaceuticals Shares Open 30% Above IPO Price In Nasdaq Debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: Theseus Pharmaceuticals Announces Pricing Of Initial Public Offering